JAK Inhibitors in Rheumatology: Implications for Paediatric Syndromes?

被引：0
|
作者：
S. A. Kerrigan
I. B. McInnes
机构：
[1] University of Glasgow,Institute of Infection, Immunity and Inflammation
来源：
Current Rheumatology Reports | 2018年 / 20卷
关键词：
JAK inhibitor; Interferonopathy; JIA; Tofacitinib; Baricitinib;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Paraneoplastic syndromes in rheumatology
    Bernhard Manger
    Georg Schett
    Nature Reviews Rheumatology, 2014, 10 : 662 - 670
  • [22] Paraneoplastic syndromes in rheumatology
    Strunz, Patrick-Pascal
    Schmalzing, Marc
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2023, 82 (03): : 212 - 219
  • [23] Paraneoplastic syndromes in rheumatology
    Schmalzing, Marc
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2018, 77 (04): : 309 - 321
  • [24] Sine syndromes in rheumatology
    Rovensky, J.
    Herold, M.
    Vasakova, M.
    WIENER KLINISCHE WOCHENSCHRIFT, 2014, 126
  • [25] Paraneoplastic syndromes in rheumatology
    Manger, Bernhard
    Schett, Georg
    NATURE REVIEWS RHEUMATOLOGY, 2014, 10 (11) : 662 - 670
  • [26] Risk/benefit trade-offs in rheumatology: rofecoxib revisited in the era of JAK inhibitors
    Hazlewood, Glen S.
    RHEUMATOLOGY, 2023, 62 (12) : 3773 - 3775
  • [27] How COVID-19 affects patients receiving anticytokine and JAK inhibitors in rheumatology and dermatology
    Chang, Ting Yi Jessica
    Pope, Janet E.
    IMMUNOTHERAPY, 2020, 12 (15) : 1115 - 1120
  • [28] Paediatric rheumatology - A global perspective
    Sawhney, S
    Magalhaes, CS
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2006, 20 (02): : 201 - 221
  • [29] The spectrum of paediatric and adolescent rheumatology
    Davies, K
    Copeman, A
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2006, 20 (02): : 179 - 200
  • [30] Where are the innovations in paediatric rheumatology?
    Thomas J. A. Lehman
    Nature Reviews Rheumatology, 2013, 9 : 326 - 327
12345